Chinacontinues todominate the project-basedmarket with 60% ofthevolume of projectstransacted (down from 73% in 2005) with Indianext with a 15% share of the market volume (up from 3% in 2005).
Many eye-vitamin formulations currently on the market are based on research conducted by the National Institutes of Health in a project called Age-Related Eye Disease Study, or AREDS. The first phase of the clinical trial, completed in 2001, found that a specific combination of vitamins C and E, along with beta-carotene and zinc, reduced the risk of age-related macular degeneration by as much as 25%.